Pseudomonas aeruginosa Bloodstream Infections: a short-course of antibiotic therapy is possible if the source of infection is controlled.

A randomized controlled trial including 604 patients with gram-negative bloodstream infections (BSI) – including both Enterobacteriaceae and glucose non-fermenting gram-negative organisms (e.g.: Pseudomonas aeruginosa) - found that patients treated with 7 days of antibiotics, in the setting of appropriate source control, had comparable outcomes to those receiving 14 days of therapy. However, th...